These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 12647691)

  • 1. FDA notifications. Product tampering labels Ziagen as Combivir.
    AIDS Alert; 2002 Aug; 17(8):102. PubMed ID: 12647691
    [No Abstract]   [Full Text] [Related]  

  • 2. Counterfit drugs: check Combivir, Serostim, Epogen.
    James JS
    AIDS Treat News; 2002 May; (380):3-4. PubMed ID: 12085844
    [No Abstract]   [Full Text] [Related]  

  • 3. FDA notifications. Tentative approval given for combination of abacavir, lamivudine & zidovudine tablets.
    AIDS Alert; 2009 Sep; 24(9):106. PubMed ID: 19928326
    [No Abstract]   [Full Text] [Related]  

  • 4. Trizivir on the market.
    Kerr C
    Trends Microbiol; 2001 Jan; 9(1):13. PubMed ID: 11166234
    [No Abstract]   [Full Text] [Related]  

  • 5. FDA notifications. FDA tentatively approves fixed-dose lamivudine/zidovudine.
    AIDS Alert; 2010 Dec; 25(12):142-3. PubMed ID: 21328815
    [No Abstract]   [Full Text] [Related]  

  • 6. AIDS foundation seeks withdrawal of approval for HIV drug combination.
    Clarke B
    Lancet Infect Dis; 2003 Oct; 3(10):604. PubMed ID: 14558502
    [No Abstract]   [Full Text] [Related]  

  • 7. FDA notifications. Tentative approval for generic lamivudine/zidovudine.
    AIDS Alert; 2007 Oct; 22(10):119-20. PubMed ID: 18416011
    [No Abstract]   [Full Text] [Related]  

  • 8. FDA notifications. Lamivudine/zidovudine tab tentatively approved.
    AIDS Alert; 2009 Jul; 24(7):83-4. PubMed ID: 19705579
    [No Abstract]   [Full Text] [Related]  

  • 9. FDA notifications. Lamivudine/zidovudine combination approved for pediatric use.
    AIDS Alert; 2009 Sep; 24(9):105. PubMed ID: 19938311
    [No Abstract]   [Full Text] [Related]  

  • 10. Treatment intensification with abacavir in HIV-infected patients with at least 12 weeks previous lamivudine/zidovudine treatment.
    Rozenbaum W; Katlama C; Massip P; Bentata M; Zucman D; Delfraissy JF; Trepo C; David F; Lanier ER; Vavro C; Mamet JP
    Antivir Ther; 2001 Jun; 6(2):135-42. PubMed ID: 11491418
    [TBL] [Abstract][Full Text] [Related]  

  • 11. FDA notifications. Tentative approval for fixed-dose combo abacavir/lamivudine.
    AIDS Alert; 2009 Feb; 24(2):22. PubMed ID: 19219952
    [No Abstract]   [Full Text] [Related]  

  • 12. FDA notifications. Generic lamivudine/zidovudine approved.
    AIDS Alert; 2009 Jul; 24(7):82. PubMed ID: 19705578
    [No Abstract]   [Full Text] [Related]  

  • 13. FDA notifications. Generic abacavir and lamivudine combo approved.
    AIDS Alert; 2008 Oct; 23(10):115. PubMed ID: 18935685
    [No Abstract]   [Full Text] [Related]  

  • 14. FDA notifications. Fixed dose ART approved by FDA.
    AIDS Alert; 2011 Mar; 26(3):35-6. PubMed ID: 21539043
    [No Abstract]   [Full Text] [Related]  

  • 15. AIDS treatment. A step toward cheaper anti-HIV therapy.
    Cohen J
    Science; 2005 Feb; 307(5710):653. PubMed ID: 15692020
    [No Abstract]   [Full Text] [Related]  

  • 16. FDA approves two combo brand-name AIDS drugs.
    Med Health; 2004 Aug; 58(31):3-4. PubMed ID: 15368717
    [No Abstract]   [Full Text] [Related]  

  • 17. FDA notifications. FDA approval for generic lamivudine/zidovudine.
    AIDS Alert; 2008 Jan; 23(1):12. PubMed ID: 18572476
    [No Abstract]   [Full Text] [Related]  

  • 18. Clinical trial that led to FDA approval of zidovudine is published.
    Clin Pharm; 1987 Oct; 6(10):752. PubMed ID: 3333341
    [No Abstract]   [Full Text] [Related]  

  • 19. Two drugs in one pill.
    Vazquez E
    Posit Aware; 1997; 8(6):19. PubMed ID: 11364854
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Zidovudine approved by FDA for treatment of AIDS.
    Clin Pharm; 1987 Jun; 6(6):431,435. PubMed ID: 3319360
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.